Association between the angiotensin-converting enzyme (insertion/deletion) and angiotensin II type 1 receptor (A1166C) polymorphisms and breast cancer among Brazilian women
Open Access
- 1 March 2009
- journal article
- other
- Published by SAGE Publications in Journal of the Renin-Angiotensin-Aldosterone System
- Vol. 10 (1) , 51-58
Abstract
Introduction.We evaluated the association between components of the renin-angiotensin system and the development of breast cancer in a case-control study by means of angiotensin-converting enzyme (ACE) insertion/deletion (I/D) and angiotensin II type 1 (AT1)-receptor A1166C polymorphisms.Methods. Genotyping was performed by PCR-RFLP (restriction fragment length polymorphism) or PCR (polymerase chain reaction) using genomic DNA extracted from buccal cells of subjects with (101 cases) or without (307 controls) breast cancer.Results.The frequencies of genotypes for ACE were: DD, ID and II (in %: cases: 60; 20; 20; controls: 46; 37; 17; p=0.019, χ2); and for AT1receptor were:AA,AC and CC (in %: cases: 65; 30; 5; controls: 51; 44; 5; p=0.114, χ2).The results suggested that the A1166C polymorphism was not associated with breast cancer risk. On the other hand, for the ACE (I/D), there seemed to be different risks for cancer between cases and controls.Conclusions.The ID genotype was less frequently associated with the disease than were the DD or II; that is, women with the ID genotype were 3.1 times less likely to develop breast cancer than those with the other genotypes.The ID genotype might be protective against breast cancer and the ACE (I/D) polymorphism a possible target for developing genetic markers for breast cancer.Keywords
This publication has 33 references indexed in Scilit:
- ACE PolymorphismsCirculation Research, 2006
- Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasisBiochemical and Biophysical Research Communications, 2002
- Growth stimulatory angiotensin II type-1 receptor is upregulated in breast hyperplasia and in situ carcinoma but not in invasive carcinomaHistochemistry and Cell Biology, 2001
- Differences between Squamous Cell Carcinoma and Keratoacanthoma in Angiotensin Type-1 Receptor ExpressionThe American Journal of Pathology, 2001
- Angiotensin II type 1 receptor expression in human breast tissuesBritish Journal of Cancer, 1997
- AT1 angiotensin II receptor subtype in the human larynx and squamous laryngeal carcinomaCancer Letters, 1996
- Growth or antigrowthJournal Of Hypertension, 1995
- The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer.Proceedings of the National Academy of Sciences of the United States of America, 1995
- Molecular cloning and sequencing of the gene encoding human angiotensin II type 1 receptorBiochemical and Biophysical Research Communications, 1992
- An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.Journal of Clinical Investigation, 1990